Document Detail


Effect of bispectral index (BIS) monitoring on postoperative recovery and sevoflurane consumption among morbidly obese patients undergoing laparoscopic gastric banding.
MedLine Citation:
PMID:  18630768     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Early and uneventful postoperative recovery of morbidly obese patients remains a challenge for anesthesiologists. It could be valuable to titrate the administration of inhaled anesthetic, such as sevoflurane, in morbid obese patients, in order to shorten emergence using bispectral index (BIS) monitoring. It would be a great advantage if BIS permitted a more rapid recovery and less consumption in morbidly obese patients with a high cost inhaled agent. The aim of the study is to show whether the titration of sevoflurane based on the BIS monitoring would allow shortening of recovery time in morbidly obese patients and to evaluate whether BIS monitoring would contribute to reduce the amount of sevoflurane administered while providing an adequate anesthesia. PATIENTS AND METHODS: Thirty morbidly obese ASA I & II patients undergoing laparoscopic gastric banding (LAGB) procedures were studied. In the first group (15 patients), patients were anesthetized without the use of BIS (non BIS or control group), and sevoflurane being administered according to standard clinical practice (control group). In the second group (15 patients), sevoflurane was titrated to maintain a BIS value between 40 and 60 during surgery, and then 60-70 during 15 min prior to the end of surgery (BIS group). Recovery times were recorded. Time to extubation was also noted, as well as the time to achieve a modified Aldrete score of 9 were evaluated subsequently at 10-min intervals until 3 h after surgery by nurses who had no knowledge of the study. Sevoflurane consumption was calculated using the vaporizer weighing method. RESULTS: Awakening and extubation times were significantly shorter in the BIS group (P < 0.05). In the BIS (vs. non BIS) group, there were no significant differences observed in the time to obtain an Aldrete score of 9. The sevoflurane consumption and cost in the BIS group were lower than in the non BIS group (P < 0.05). CONCLUSION: Bispectral index monitoring during anesthesia for morbidly obese patients provides statistically significant reduction in recovery times. It also has the added advantage in decreasing sevoflurane consumption.
Authors:
Osama Ibraheim; Ahamad Alshaer; Khalid Mazen; Abdelazeem El-Dawlaty; Ahmed Turkistani; Khaled Alkathery; Tariq Al-Zahrani; Abdullah Al-Dohayan; Areej Bukhari
Related Documents :
19998238 - Transient salt wasting in pomc-deficiency due to infection induced stress.
17525588 - Incidence of propofol infusion syndrome during noninvasive radiofrequency ablation for ...
2324478 - The effect of age on the relative potency of midazolam and diazepam for sedation in upp...
7900578 - Rectal thiopental sodium for sedation of pediatric patients undergoing mr and other ima...
20211518 - Quantitative ultrasound of the calcaneus in hemodialysis patients.
6120108 - Oral contraceptive exposure of amenorrheic women with and without prolactinomas.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Middle East journal of anesthesiology     Volume:  19     ISSN:  0544-0440     ISO Abbreviation:  Middle East J Anesthesiol     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-07-17     Completed Date:  2008-10-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8604187     Medline TA:  Middle East J Anesthesiol     Country:  Lebanon    
Other Details:
Languages:  eng     Pagination:  819-30     Citation Subset:  IM    
Affiliation:
Department of Anesthesia, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia. osamaibraheim@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anesthesia Recovery Period*
Anesthesia, General*
Anesthetics, Inhalation* / administration & dosage
Anesthetics, Intravenous
Atracurium
Bariatric Surgery*
Electroencephalography / drug effects*
Female
Fentanyl
Humans
Laparoscopy*
Male
Methyl Ethers* / administration & dosage
Middle Aged
Monitoring, Intraoperative / methods*
Neuromuscular Nondepolarizing Agents
Obesity, Morbid / surgery*
Postoperative Complications / epidemiology
Prospective Studies
Chemical
Reg. No./Substance:
0/Anesthetics, Inhalation; 0/Anesthetics, Intravenous; 0/Methyl Ethers; 0/Neuromuscular Nondepolarizing Agents; 28523-86-6/sevoflurane; 437-38-7/Fentanyl; 64228-79-1/Atracurium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tracheostomy under jet-ventilation--an alternative approach to ventilating patients undergoing surgi...
Next Document:  Neuromuscular effects of cisatracurium in morbidly obese patients.